- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01801943
Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment (WalkCog-MCI)
September 21, 2022 updated by: Pennington Biomedical Research Center
The purpose of this study is to determine the effects of a coordinated intervention of cognitive remediation training (CRT) and walking intervention on cognition and gait in the elderly.
Study Overview
Status
Terminated
Conditions
Detailed Description
This is a single blind randomized study designed to understand the effects of different interventions, walking interventions and cognitive remediation in particular, towards cognition and gait in the elderly.
The study uses a 4 arm approach consisting of 4 intervention groups, with each intervention lasting for 12 weeks.
The investigators will investigate the effect of each intervention towards cognitive function and gait.
All interventions will be conducted on site at the Pennington Biomedical Research Center, and will be focused on determining the effects of different combinations of walking, cognitive remediation, healthy living courses, and reading.
Cognitive measures will include objective clinical measures related to dementia, and the gait analysis will include in clinic and "free living" measures related to falls.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 85 years (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women meeting all criteria listed below will be included in the study:
- Subjects between 65-85 years of age inclusive
- Subjects with Short Physical Performance Battery of 10 or greater
- Subjects averaging less than 5,000 steps per day
- Subjects with Mini Mental State Exam 25-28, inclusive
- Subjects with normal for age physical-neurological exam
- Subjects able to walk a city block without a walking aid
- Written Informed Consent obtained PRIOR to performing any study procedures
Exclusion Criteria:
- Subjects with difficult walking due to pain or posture
- Subjects with difficulty in using computer due to significant visual and/or fine motor impairment
- Subjects with large weight loss (>15 Kilogram) in the last 12 months
- Subjects with geriatric depression scale > 9.
- Subjects with Malignancies in the past 5 years, with the exception of skin cancer therapeutically controlled
- Subjects with abnormal electrocardiogram results. These include: a resting heart rate below 40 bpm or above 100 bpm, previously unknown and/or untreated atrial fibrillation or flutter, evidence of a third degree A-V block, a previously undocumented left bundle branch block, S-T segment depression of greater than 2 mm, evidence of a previous MI, or any other findings that in the clinical judgment of the medical investigator preclude participation in an exercise intervention.
- Subjects with shortness of breath, exertional angina, uncontrolled high blood pressure or any other chronic medical condition deemed by the physician to preclude participation in an exercise intervention.
- Subjects with any other medical condition or disease that is life-threatening or that can interfere with, or be aggravated by, exercise.
- Subjects who currently smoke.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Remediation Therapy Group
30 minute Cognitive Remediation Therapy and 60 minute Healthy Living Class three time per week
|
30 min Cognitive Remediation Therapy + 60 Min Healthy Living class 3x week
|
|
Experimental: Walking Intervention Group
60 minutes of walking and 30 minutes of reading stimulation three times a week
|
60 min Walking Intervention + 30 min low interface reading 3x week
|
|
Experimental: Combination Group
30 minutes of Cognitive Remediation therapy and 60 minutes of walking three times a week
|
30 min Cognitive Remediation Therapy + 60 min Walking Intervention 3x week
|
|
Experimental: Healthy Living Group
60 minute Healthy Living Class and 30 minutes of reading stimulation three times a week.
|
60 Min Healthy Living class + 30 min low interface reading 3x week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effects of interventions on cognition
Time Frame: 6 months
|
Standard psychometric tests will be used to measure cognition
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effects of interventions on gait
Time Frame: 6 months
|
Standard laboratory assessments and accelerometers will be used to measure gait.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jeffrey Keller, PhD, Pennington Biomedical Research Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
February 26, 2013
First Submitted That Met QC Criteria
February 27, 2013
First Posted (Estimate)
March 1, 2013
Study Record Updates
Last Update Posted (Actual)
September 23, 2022
Last Update Submitted That Met QC Criteria
September 21, 2022
Last Verified
June 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PBRC 12032
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Impairment
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
University of EdinburghNHS LothianNot yet recruitingCognitive Impairment | Anesthesia | Cognitive Impairment, Mild | Anesthesia Brain Monitoring | Cognitive Impairment, Progressive | Anesthesia Depth MonitoringUnited Kingdom
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
-
Universidad de ZaragozaRecruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive ImpairmentSpain
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Region SkaneLund University; Berry LabCompletedMemory Impairment | Cognitive Impairment, MildSweden
-
Sunnybrook Health Sciences CentreRecruitingMild Cognitive Impairment | Vascular Cognitive ImpairmentCanada
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University of HawaiiRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
Clinical Trials on Cognitive Remediation Therapy Group
-
Manhattan Psychiatric CenterNathan Kline Institute for Psychiatric ResearchCompletedSchizophreniaUnited States
-
VA Office of Research and DevelopmentIndiana University School of MedicineCompleted
-
Yale UniversityCompletedCancer | Cancer of the ProstateUnited States
-
Gemma Garrido GarcíaCompleted
-
Fundació Sant Joan de DéuCompletedIndication for Modification of Patient Cognitive StatusSpain
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Mental DisordersUnited States
-
Douglas Mental Health University InstituteCanadian Institutes of Health Research (CIHR)CompletedPsychosis | Social PhobiaCanada
-
Beykoz UniversityUskudar University; Istanbul Nisantasi UniversityRecruitingCognitive Dysfunction | Schizophrenia Disorders | Emotion Regulation DisordersTurkey
-
South London and Maudsley NHS Foundation TrustCompleted
-
Fraser HealthMinistry of Social Development and Poverty Reduction, British ColumbiaCompletedSchizophrenia and Related Disorders | Psychotic DisorderCanada